drug
rilpivirine hydrochloride ODT
Marketedupdated 5mo agoby $JNJ JOHNSON & JOHNSON
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for hiv-1 infection and hiv infection.
all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 15, 2027
166 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Oct 23, 2037formulationUS 11065198
FDA exclusivities (4)
- Sep 15, 2027PEDPediatric (6mo bonus)350d
- Sep 15, 2027PEDPediatric (6mo bonus)350d
- Mar 15, 2027NPPNew Product (3y)166d
- Mar 15, 2027NPNP166d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that